{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:28:49Z","timestamp":1782761329890,"version":"3.54.5"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Gastroduodenal and small intestinal permeability are increased in patients with Crohn's disease (CD) and intensive care patients. The relevance of colonic permeability has not yet been adequately investigated. The aim of this study was to investigate the clinical value of sucralose excretion as indicator for colonic permeability in these patient groups.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> After oral administration of four sugars and subsequent analysis of urinary excretion, gastroduodenal and intestinal permeability were calculated from saccharose excretion and lactulose\/mannitol (L\/M) ratio over 5\u00a0h, and sucralose excretion from 5 to 26\u00a0h in 100 healthy controls, 29\u00a0CD and 35 patients after coronary surgery (CABG).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In controls, sucralose excretion was highly variable (0\u00b767\u00a0\u00b1\u00a00\u00b792%) and not related to small intestinal permeability. In CD and CABG, L\/M ratio was increased (0\u00b7054\u00a0\u00b1\u00a00\u00b7060; 0\u00b7323\u00a0\u00b1\u00a00\u00b7253 vs. 0\u00b7018\u00a0\u00b1\u00a00\u00b7001 in controls). Sucralose excretion was increased in 77% of CABG but only in 7% of CD. There was an association between gastroduodenal and intestinal permeability in CD and CABG (<jats:italic>r<\/jats:italic>\u00a0=\u00a00\u00b772, and <jats:italic>r<\/jats:italic>\u00a0=\u00a00\u00b751), but sucralose excretion was not related to either one of these two parameters. Other than a weak association between sucralose and length of stay in intensive care in CABG patients (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7099), sucralose excretion was not related to clinical outcome.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The proposed cut\u2010off for normal sucralose excretion is 2\u00b711%, but its high variability and lack of association to gastrointestinal permeability or clinical outcome leave it open, if it can provide information beyond established permeability tests.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2008.02075.x","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T10:33:18Z","timestamp":1232447598000},"page":"139-144","source":"Crossref","is-referenced-by-count":19,"title":["Clinical relevance of measuring colonic permeability"],"prefix":"10.1111","volume":"39","author":[{"given":"V.","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"B\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Buhner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Von Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90882-H"},{"key":"e_1_2_6_3_2","first-page":"1891","article-title":"Increased gastric and intestinal permeability in patients with Crohn's disease","volume":"92","author":"Wyatt J","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323000703500107"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2004.00392.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2004.01347.x"},{"issue":"1","key":"e_1_2_6_7_2","first-page":"49","article-title":"Gut barrier function: the simultaneous measurement of colonic and small intestinal permeability in surgical patients","volume":"91","author":"Anderson ADG","year":"2004","journal-title":"Br J Surg"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.085373"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70636-5"},{"key":"e_1_2_6_10_2","first-page":"1206","article-title":"A triple sugar test of intestinal permeability in patients with inflammatory bowel disease","volume":"91","author":"Anderson ADG","year":"2004","journal-title":"Br J Surg"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2008.03.018"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc4891"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.065557"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.1399"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.06.012"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200750056637"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.06.038"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2005.02.047"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199607000-00013"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000834"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.129841"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.4.483"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-8351-9010-8","volume-title":"Toxikokinetik F\u00fcr Naturwissenschaftler","author":"Fuhrmann GF","year":"2006"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/japr\/15.1.154"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087426"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2008.02075.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2008.02075.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:03:53Z","timestamp":1697234633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2008.02075.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1365-2362.2008.02075.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2008.02075.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}